Hepatitis A,B,-combined adjuvanted vaccine
    41.
    发明公开
    Hepatitis A,B,-combined adjuvanted vaccine 失效
    Kombiniertes肝炎A-和B-Vakzin mit Adjuvans。

    公开(公告)号:EP0339667A2

    公开(公告)日:1989-11-02

    申请号:EP89107762.0

    申请日:1989-04-28

    IPC分类号: A61K39/29 A61K39/295

    摘要: A hepatitis A,B-combined adjuvanted vaccine is disclosed in this application, said vaccine comprising an inactivated hepatitis A virus antigen, a hepatitis B virus surface antigen and an adjuvant. The present vaccine is obtained by causing the antigens to be adsorbed to the adjuvant. According to the present invention, the infection with not only hepatitis A virus but also hepatitis B vrius can be prevented without causing any interference due to the mixing of these antigens and any severe side-effects, and the anti-hepatitis A virus antibody titer is greatly enhanced by the mixing.

    摘要翻译: 在本申请中公开了甲型肝炎乙型联合佐剂疫苗,所述疫苗包含灭活的甲型肝炎病毒抗原,乙型肝炎病毒表面抗原和佐剂。 通过使抗原吸附到佐剂上获得本疫苗。 根据本发明,可以防止由于这些抗原的混合引起的任何干扰和任何严重的副作用,而且不仅甲型肝炎病毒而且乙型肝炎病毒的感染,并且抗甲型肝炎病毒抗体滴度为 通过混合大大增强。

    Gene fragments coding for the variable region of an anti-HIV antibody, chimeric anti-HIV antibodies expressed using the same, and process for their preparation
    42.
    发明公开
    Gene fragments coding for the variable region of an anti-HIV antibody, chimeric anti-HIV antibodies expressed using the same, and process for their preparation 失效
    编码由这些嵌合抗-HIV抗体和它们的制备方法表示的抗HIV抗体的可变区基因片段。

    公开(公告)号:EP0327000A2

    公开(公告)日:1989-08-09

    申请号:EP89101583.6

    申请日:1989-01-30

    摘要: Described are novel chimeric anti-human immunodeficiency virus (HIV) antibodies which comprise a constant region derived from human antibody and variable region derived from mouse monoclonal antibody, gene fragments coding for the variable region the H and L chain of chimeric anti-HIV antibodies which are effective for expression of chimeric anti-HIV antibodies having an HIV-neutralizing activity, a transformant where such gene fragments are incorporated, chimeric anti-HIV antibodies expressed therefrom and a process for their preparation. The chimeric anti-HIV antibodies of the present invention show anti-HIV neutralizing activity and are useful for the diagnosis, treatment and prevention of acquired immunodeficiency syndrome (AIDS) caused by HIV without side effects such as anaphylactic shock or serum sickness.

    摘要翻译: 描述的是新颖的,其包括来自人抗体和小鼠单克隆抗体的可变区的恒定区的嵌合抗 - 人免疫缺陷病毒(HIV)抗体,基因片段编码嵌合抗-HIV抗体的H和L链的可变区,其 有效用于具有HIV中和活性,其中一个检查基因片段掺入转化体,从那里过表达嵌合抗HIV抗体和用于制备它们的方法的嵌合抗-HIV抗体的表达。 本发明显示抗HIV中和活性的和嵌合的抗HIV抗体可用于无副作用由HIV引起的诊断,治疗和预防获得性免疫缺陷综合症的(AIDS)有用:如过敏性休克或血清病。

    Potential-causing element for immunosensor
    49.
    发明公开
    Potential-causing element for immunosensor 失效
    Potentialverursachendes元素免疫传感器。

    公开(公告)号:EP0193154A2

    公开(公告)日:1986-09-03

    申请号:EP86102363.8

    申请日:1986-02-24

    IPC分类号: G01N27/30 G01N27/40

    CPC分类号: G01N33/545 G01N33/5438

    摘要: Disclosed is a potential-causing element, in the form of an electrode or a membrane, for use in immunosensors, which comprises a polypyrrole or polythiophene film bound with an antigen or an antibody. The potential-causing element can be prepared in an easy manner through electrolytic polymerization of pyrrole or thiopene so as to control the thickness of the polymer film which will develop desired immunosresponse characteristics.

    摘要翻译: 公开了用于免疫传感器的电极或膜形式的潜在的元素,其包含与抗原或抗体结合的聚吡咯或聚噻吩膜。 可以通过吡咯或噻吩的电解聚合以容易的方式制备潜在的元素,以便控制将产生所需免疫应答特性的聚合物膜的厚度。